Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMARIN CORP PLC\UKAMRN · Entity 5970 | EVP, Chief Scientific Officer | July 01, 2026 | July 15, 2026 |
| Viracta Therapeutics, Inc.SNSS · Entity 85616 | Director | June 30, 2020 | July 01, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMARIN CORP PLC\UK
Report date July 01, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 42,680 |
Last balance in matching sequence
After 2026-07-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-07-01 · Exercise / conversion · Acquired 3,688 · Balance 44,567 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3: Not applicable. Row 2 · 2026-07-01 · Tax withholding · Disposed 1,887 · Balance 42,680 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-01 · Grant · Acquired 3,688 · Balance 0 F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change.
F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026.
F3: Not applicable.
F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.
Viracta Therapeutics, Inc.
Report date June 30, 2020 · Filed July 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.26 · Expires 2030-06-30 | Direct | 60,000 |
Reported balance
After 2020-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-30 · Grant · Acquired 60,000 · Balance 60,000 F1: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2019 Filed Oct 10, 2019 00:03 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantOrdinary Shares | 199,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-052865 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,992 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: In January 2015, 399,000 restricted stock units (the "RSUs") were approved to be granted and, following the Annual General Meeting of Shareholders held in July 2015, were granted to the Reporting Person under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. The RSUs vested in two equal installments based on the Issuer's satisfaction of certain performance criteria and continued employment of the Reporting Person as provided in the Restricted Stock Unit Award Agreement between the Issuer and the Reporting Person. Vesting of the second and final installment was achieved based on a predetermined performance-based formula tied to company cash flow as determined by the Remuneration Committee of the Board of Directors, resulting in the vesting of 199,500 RSUs. F3 · price: Not applicable. F4 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:23 UTC | Viracta Therapeutics, Inc. SNSS · Entity 85616 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0000899243-19-018925 · doc4.xml · derivative · entry 1 Ketchum Steven B · CIK 0001289884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-06-28 F1 · derivative.exercise_date: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. Read SEC document |
| April 30, 2019 Filed May 3, 2019 01:05 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,771 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-19-027161 · doc4.xml · derivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,687 Underlying: Ordinary Shares · 2,771 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 30, 2019 Filed May 3, 2019 01:05 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,166 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-027161 · doc4.xml · derivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,332 Underlying: Ordinary Shares · 4,166 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 30, 2019 Filed May 3, 2019 01:05 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-19-027161 · doc4.xml · derivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,436 Underlying: Ordinary Shares · 2,604 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 30, 2019 Filed May 3, 2019 01:05 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 9,541 | $18.67 | $178,106.62 |
DisclosureSEC source: 0001209191-19-027161 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,492 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.41 to $19.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 30, 2019 Filed May 3, 2019 01:05 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,771 | $2.95 | $8,174.45 |
DisclosureSEC source: 0001209191-19-027161 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 30, 2019 Filed May 3, 2019 01:05 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 4,166 | $2.50 | $10,415.00 |
DisclosureSEC source: 0001209191-19-027161 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 30, 2019 Filed May 3, 2019 01:05 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,604 | $1.40 | $3,645.60 |
DisclosureSEC source: 0001209191-19-027161 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,771 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · derivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,458 Underlying: Ordinary Shares · 2,771 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,166 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · derivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,498 Underlying: Ordinary Shares · 4,166 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,605 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · derivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,040 Underlying: Ordinary Shares · 2,605 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 100 | $20.78 | $2,078.00 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,492 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 9,442 | $20.05 | $189,313.99 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,592 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.78 to $20.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,771 | $2.95 | $8,174.45 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 4,166 | $2.50 | $10,415.00 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 00:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,605 | $1.40 | $3,647.00 |
DisclosureSEC source: 0001209191-19-022107 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 46,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · derivative · entry 12 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,000 Underlying: Ordinary Shares · 46,000 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 240,000 Ordinary shares under the Plan. The vesting of the shares was subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 7,099 | $22.64 | $160,717.10 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,492 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.50 to $22.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 35,398 | $22.10 | $782,196.69 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,591 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $22.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 3,503 | $20.94 | $73,361.23 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,989 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $21.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 46,000 | $2.50 | $115,000.00 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,771 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · derivative · entry 11 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,229 Underlying: Ordinary Shares · 2,771 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,167 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · derivative · entry 10 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,664 Underlying: Ordinary Shares · 4,167 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,605 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · derivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,645 Underlying: Ordinary Shares · 2,605 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 9,543 | $20.67 | $197,249.04 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,492 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.42 to $21.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,771 | $2.95 | $8,174.45 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 4,167 | $2.50 | $10,417.50 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 01:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,605 | $1.40 | $3,647.00 |
DisclosureSEC source: 0001209191-19-015276 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 53,500 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 17 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 Underlying: Ordinary Shares · 53,500 shares Expires 2029-02-01 F16 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted an option to purchase 53,500 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 16 equal quarterly installments starting on May 15, 2019. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 38,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 16 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,200 Underlying: Ordinary Shares · 38,200 shares Expires not disclosed F14 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F15 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021 and January 31, 2022. F6 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 27,989 | $17.06 | $477,497.94 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,492 F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.81 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 26,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 15 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Ordinary Shares · 26,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F8 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. The first vesting event occurred on January 31, 2019. F6 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 29,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 14 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Underlying: Ordinary Shares · 29,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F7 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted 87,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The second vesting event occurred on January 31, 2019. F6 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 26,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 13 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 26,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted 80,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The third and final vesting event occurred on January 31, 2019. F6 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,770 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 12 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Ordinary Shares · 2,770 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,167 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 11 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,831 Underlying: Ordinary Shares · 4,167 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · derivative · entry 10 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Ordinary Shares · 2,604 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 40,482 | $16.94 | $685,765.08 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,481 F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F9 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 26,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F8 · shares: On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. The first vesting event occurred on January 31, 2019. F6 · price: Not applicable. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 29,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · shares: On February 1, 2017, the Reporting Person was granted 87,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The second vesting event occurred on January 31, 2019. F6 · price: Not applicable. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 26,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · shares: On February 1, 2016, the Reporting Person was granted 80,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The third and final vesting event occurred on January 31, 2019. F6 · price: Not applicable. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 9,541 | $17.49 | $166,874.95 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,297 F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.09 to $17.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,770 | $2.95 | $8,171.50 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 4,167 | $2.50 | $10,417.50 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,604 | $1.40 | $3,645.60 |
DisclosureSEC source: 0001209191-19-006639 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 00:51 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,770 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-19-000519 · doc4.xml · derivative · entry 11 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,770 Underlying: Ordinary Shares · 2,770 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 00:51 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-000519 · doc4.xml · derivative · entry 10 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,938 Underlying: Ordinary Shares · 3,750 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares is subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 00:51 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-000519 · doc4.xml · derivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Ordinary Shares · 3,750 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares is subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 00:51 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,167 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-000519 · doc4.xml · derivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,998 Underlying: Ordinary Shares · 4,167 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.